The Anti-fibrotic Effects and Mechanisms of MicroRNA-486-5p in Pulmonary Fibrosis

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Ji, Xiaoming ^a   Wu, Baiqun ^a   Fan, Jingjing ^a   Han, Ruhui ^a   Luo, Chen ^a   Wang, Ting ^a   Yang, Jingjin ^a   Han, Lei ^a,b   Zhu, Baoli ^b   Wei, Dong ^a   Chen, Jingyu ^a   Ni, Chunhui ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL; BINDING SITE; CELL PROLIFERATION; CHEMISTRY; DISEASE MODEL; DOWN REGULATION; DRUG EFFECTS; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LUNG; LUNG FIBROSIS; METABOLISM; MOUSE; NUCLEOTIDE SEQUENCE; PATHOLOGY; RNA INTERFERENCE; SILICOSIS;

ANIMALS; BASE SEQUENCE; BINDING SITES; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; LUNG; MICE; MICRORNAS; PULMONARY FIBROSIS; RNA INTERFERENCE; SILICOSIS; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84941762330     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep14131     Document Type: Article

References (52)

1. Greenberg, M. I., Waksman, J. & Curtis, J. Silicosis: a review. Dis Mon 53, 394-416 (2007).
2. WHO. The Global Occupational Health Network newsletter: elimination of silicosis. http://www.who.int/mediacentre/factsheets/fs238/en/ accessed Sept 1, 2011(2007).
3. Nathan, S. D. & Meyer, K. C. IPF clinical trial design and endpoints. Curr Opin Pulm Med 20, 463-71 (2014).
4. Nathan, S. D. & King, C. S. Treatment of pulmonary hypertension in idiopathic pulmonary fibrosis: shortfall in efficacy or trial design? Drug Des Devel Ther 8, 875-85 (2014).
5. Honeyman, L., Bazett, M., Tomko, T. G. & Haston, C. K. MicroRNA profiling implicates the insulin-like growth factor pathway in bleomycin-induced pulmonary fibrosis in mice. Fibrogenesis Tissue Repair 6, 16 (2013).
6. Gao, Y. et al. Baicalein attenuates bleomycin-induced pulmonary fibrosis in rats through inhibition of miR-21. Pulm Pharmacol Ther 26, 649-54 (2013).
7. Steen, V. D. & Medsger, T. A. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 66, 940-4 (2007).
8. Tansey, D. et al. Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology 44, 585-96 (2004).
9. Leung, C. C., Yu, I. T. & Chen, W. Silicosis. Lancet 379, 2008-18 (2012).
10. Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215-33 (2009).
11. Lee, R. C., Feinbaum, R. L. & Ambros, V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843-54 (1993).
12. Wightman, B., Ha, I. & Ruvkun, G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75, 855-62 (1993).
13. Guo, H., Ingolia, N. T., Weissman, J. S. & Bartel, D. P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466, 835-40 (2010).
14. Ramachandran, S. et al. Post-transcriptional regulation of cystic fibrosis transmembrane conductance regulator expression and function by microRNAs. Am J Respir Cell Mol Biol 49, 544-51 (2013).
15. Simone, B. A. et al. microRNA alterations driving acute and late stages of radiation-induced fibrosis in a murine skin model. Int J Radiat Oncol Biol Phys 90, 44-52 (2014).
16. Pandit, K. V., Milosevic, J. & Kaminski, N. MicroRNAs in idiopathic pulmonary fibrosis. Transl Res 157, 191-9 (2011).
17. Liang, H. et al. Integrated analyses identify the involvement of microRNA-26a in epithelial-mesenchymal transition during idiopathic pulmonary fibrosis. Cell Death Dis 5, e1238 ( 2014).
18. Lazo, J. S., Hoyt, D. G., Sebti, S. M. & Pitt, B. R. Bleomycin: a pharmacologic tool in the study of the pathogenesis of interstitial pulmonary fibrosis. Pharmacol Ther 47, 347-58 (1990).
19. Santrach, P. J., Askin, F. B., Wells, R. J., Azizkhan, R. G. & Merten, D. F. Nodular form of bleomycin-related pulmonary injury in patients with osteogenic sarcoma. Cancer 64, 806-11 (1989).
20. Munger, J. S. et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96, 319-28 (1999).
21. Lu, J. et al. MicroRNA expression profiles classify human cancers. Nature 435, 834-8 (2005).
22. Thum, T. et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456, 980-4 (2008).
23. Roderburg, C. et al. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 53, 209-18 (2011).
24. Fazi, F. & Blandino, G. MicroRNAs: Non Coding Pleiotropic Factors in Development, Cancer Prevention and Treatment. Microrna 2, 81 (2013).
25. Liu, G. et al. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med 207, 1589-97 (2010).
26. Pandit, K. V. et al. Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 182, 220-9 (2010).
27. Lino Cardenas, C. L. et al. miR-199a-5p Is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1. PLoS Genet 9, e1003291 ( 2013).
28. Small, E. M. et al. Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486. Proc Natl Acad Sci USA 107, 4218-23 (2010).
29. Zhou, D. et al. Small, membrane-bound, alternatively spliced forms of ankyrin 1 associated with the sarcoplasmic reticulum of mammalian skeletal muscle. J Cell Biol 136, 621-31 (1997).
30. Gallagher, P. G., Romana, M., Tse, W. T., Lux, S. E. & Forget, B. G. The human ankyrin-1 gene is selectively transcribed in erythroid cell lines despite the presence of a housekeeping-like promoter. Blood 96, 1136-43 (2000).
31. Lulli, V. et al. MicroRNA-486-3p regulates gamma-globin expression in human erythroid cells by directly modulating BCL11A. PLoS One 8, e60436 ( 2013).
32. Navon, R. et al. Novel rank-based statistical methods reveal microRNAs with differential expression in multiple cancer types. PLoS One 4, e8003 (2009).
33. Wang, J. et al. Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer. Oncogene 33, 1181-9 (2014).
34. Cai, H. et al. Plasma microRNAs serve as novel potential biomarkers for early detection of gastric cancer. Med Oncol 30, 452 (2013).
35. Mosakhani, N. et al. MicroRNA profiling differentiates colorectal cancer according to KRAS status. Genes Chromosomes Cancer 51, 1-9 (2012).
36. Chan, E. et al. MicroRNA signatures differentiate melanoma subtypes. Cell Cycle 10, 1845-52 (2011).
37. Yu, J., Li, A., Hong, S. M., Hruban, R. H. & Goggins, M. MicroRNA alterations of pancreatic intraepithelial neoplasias. Clin Cancer Res 18, 981-92 (2012).
38. Hummel, R. et al. Chemotherapy-induced modification of microRNA expression in esophageal cancer. Oncol Rep 26, 1011-7 (2011).
39. Yang, S. et al. miR-31 is a negative regulator of fibrogenesis and pulmonary fibrosis. FASEB J 26, 3790-9 (2012).
40. Yang, S. et al. Participation of miR-200 in pulmonary fibrosis. Am J Pathol 180, 484-93 (2012).
41. Xiao, J. et al. miR-29 inhibits bleomycin-induced pulmonary fibrosis in mice. Mol Ther 20, 1251-60 (2012).
42. Fernandez, I. E. & Eickelberg, O. New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis. Lancet 380, 680-8 (2012).
43. Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C. & Brown, R. A. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3, 349-63 (2002).
44. Lee, C. G., Cho, S., Homer, R. J. & Elias, J. A. Genetic control of transforming growth factor-beta1-induced emphysema and fibrosis in the murine lung. Proc Am Thorac Soc 3, 476-477 (2006).
45. Brown, K. A., Pietenpol, J. A. & Moses, H. L. A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling. J Cell Biochem 101, 9-33 (2007).
46. Blobe, G. C., Schiemann, W. P. & Lodish, H. F. Role of transforming growth factor beta in human disease. N Engl J Med 342, 1350-8 (2000).
47. Midorikawa, Y. et al. Allelic imbalances and homozygous deletion on 8p23.2 for stepwise progression of hepatocarcinogenesis. Hepatology 49, 513-22 (2009).
48. Bushati, N. & Cohen, S. M. microRNA functions. Annu Rev Cell Dev Biol 23, 175-205 (2007).
49. Oh, H. K. et al. Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer. Clin Cancer Res 17, 2657-67 (2011).
50. Hung, C. F., Rohani, M. G., Lee, S. S., Chen, P. & Schnapp, L. M. Role of IGF-1 pathway in lung fibroblast activation. Respir Res 14, 102 (2013).
51. Lodish, H. F., Zhou, B., Liu, G. & Chen, C. Z. Micromanagement of the immune system by microRNAs. Nat Rev Immunol 8, 120-30 (2008).
52. Hemmati, A. A., Nazari, Z. & Samei, M. A comparative study of grape seed extract and vitamin E effects on silica-induced pulmonary fibrosis in rats. Pulm Pharmacol Ther 21, 668-74 (2008).